Archives for September 27, 2004

← 2004

First approval for Yamanouchi's OCAS tech

Yamanouchi Pharmaceutical of Japan has been granted the first approval - in the Netherlands - for a product based on its proprietary OCAS drug delivery technology.

Girindus wins oligonucleotide award

Germany's Girindus is this year's recipient of the Product Differentiation Award sponsored by consulting firm Frost & Sullivan for its innovative developments in the commercial production of oligonucleotides.

Chr Hansen launches natural red range

Number one natural colours firm Chr Hansen builds on ambitions to penetrate deeper into this growing market with the launch of a new range of natural reds that tackle stability for beverage formulations, reports Lindsey Partos.

IBM expands RFID unit; tackles middleware

IBM has announced a $250 million (€203m) investment programme in radiofrequency identification (RFID) and will boost the number of employees working in this area by 1,000.

Altana planning chemicals acquisition?

Germany's chemical and pharmaceuticals firm Altana is considering an acquisition valued at up to €500 million to strengthen its specialty chemicals division, according to chief executive Nikolaus Schweickart.

Pharma capital investments round-up

This week has seen several companies unveil significant capital investments in new production and research units, and once again production facilities for biological drugs - currently said to be suffering from undercapacity - feature strongly.